Journal: Biomolecules
Article Title: Cytokines and Chemokines in SARS-CoV-2 Infections—Therapeutic Strategies Targeting Cytokine Storm
doi: 10.3390/biom11010091
Figure Lengend Snippet: Summary of selected therapeutic strategies targeting the cytokine storm in COVID-19 in phase 3 and 4 clinical trials registered on clinicaltrials.gov and clinicaltrialsregister.eu databases Abbreviations: SOC, standard of care; IMV, invasive mechanical ventilation; MV, mechanical ventilation; ICU, intensive care unit; ECMO, extracorporeal membrane oxygenation.
Article Snippet: Infliximab is currently tested in a randomised phase 3 clinical trial among other immune-modulating candidates for treating COVID-19 as an add-on therapy to the already approved remdesivir (Gilead Sciences, Inc., Foster City, CA, USA) (NCT04593940).
Techniques: Injection, Variant Assay